Serum IL-17 and IL-23 levels can distinguish between severe and non-severe inflammatory bowel disease

被引:0
|
作者
Lucaciu, L. [1 ,2 ]
Ilies, M. [3 ]
Iuga, C. [3 ,4 ]
Seicean, A. [1 ,2 ]
机构
[1] Iuliu Hatieganu Univ Med & Pharm, Gastroenterol & Hepatol, Cluj Napoca, Romania
[2] Reg Inst Gastroenterol & Hepatol, Cluj Napoca, Romania
[3] Iuliu Hatieganu Univ Med & Pharm, Dept Pharmaceut Anal, Fac Pharm, Cluj Napoca, Romania
[4] MedFuture Res Ctr Adv Med, Dept Prote & Metabol, Cluj Napoca, Romania
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P136
引用
收藏
页码:S163 / S163
页数:1
相关论文
共 50 条
  • [41] IL-23 is required for the development of severe egg-induced immunopathology in schistosomiasis and for lesional expression of IL-17
    Rutitzky, Laura I.
    Bazzone, Lindsey
    Shainheit, Mara G.
    Joyce-Shaikh, Barbara
    Cua, Daniel J.
    Stadecker, Miguel J.
    JOURNAL OF IMMUNOLOGY, 2008, 180 (04): : 2486 - 2495
  • [42] A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis
    Campa, Molly
    Mansouri, Bobbak
    Warren, Richard
    Menter, Alan
    DERMATOLOGY AND THERAPY, 2016, 6 (01) : 1 - 12
  • [43] A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis
    Molly Campa
    Bobbak Mansouri
    Richard Warren
    Alan Menter
    Dermatology and Therapy, 2016, 6 : 1 - 12
  • [44] The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23→IL-17 axis
    Sheibanie, Amir F.
    Yen, Jui-Hung
    Khayrullina, Tanzilya
    Emig, Frances
    Zhang, Ming
    Tuma, Ronald
    Ganea, Doina
    JOURNAL OF IMMUNOLOGY, 2007, 178 (12): : 8138 - 8147
  • [45] The role of IL-23/IL-17 axis in the etiopathogenesis of Behcet's disease
    Leng, Rui-Xue
    Chen, Gui-Mei
    Pan, Hai-Feng
    Ye, Dong-Qing
    CLINICAL RHEUMATOLOGY, 2010, 29 (10) : 1209 - 1209
  • [46] How to choose between IL-17 inhibitors and IL-23 inhibitors for psoriasis
    Amin, Mina
    Lee, Erica B.
    Wu, Jashin J.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2019, 30 (04) : 374 - 375
  • [47] Evolution of IL-23 Blockade in Inflammatory Bowel Disease
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    JOURNAL OF CROHNS & COLITIS, 2022, 16 (SUPPL 2):
  • [48] Interleukin 17 (IL-17) and interleukin 23 (IL-23) levels are modulated by compressive orthodontic forces in humans
    Allgayer, Susiane
    de Menezes, Luciane Macedo
    Batista, Eraldo L., Jr.
    JOURNAL OF THE WORLD FEDERATION OF ORTHODONTISTS, 2019, 8 (04) : 148 - 152
  • [49] The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
    Liu, Taoming
    Li, Sheng
    Ying, Shuni
    Tang, Shunli
    Ding, Yuwei
    Li, Yali
    Qiao, Jianjun
    Fang, Hong
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [50] Total Glycosides of Peony Protects Against Inflammatory Bowel Disease by Regulating IL-23/IL-17 Axis and Th17/Treg Balance
    Li, Qinglin
    Shan, Qiyuan
    Sang, Xianan
    Zhu, Ruyi
    Chen, Xiaocheng
    Cao, Gang
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2019, 47 (01): : 177 - 201